Rotation Medical Bioinductive Implant
DevicePlacement of bioinductive implant over repair of insertional Achilles tendinopathy
NCT Number: NCT02811003
To evaluate bioinduction of new tissue and tendon healing after implantation of the Rotation Medical Bioinductive Implant used as adjunct to surgical repair in the treatment of insertional Achilles tendonitis.
Looking for future studies?
Notify Me21 year and older
All sexes
Interventional
Not applicable
MedStar Union Memorial Hospital, Baltimore, Maryland, United States
This is a prospective, non-randomized, single-arm study conducted under a common protocol designed to evaluate long-term outcomes following open treatment and implantation of the Rotation Medical Bioinductive Implant to treat insertional Achilles tendinopathy.
Up to 20 subjects will be enrolled and treated with the Rotation Medical Bioinductive Implant.
Enrollment is anticipated to take up to 12 months and all subjects will be followed for two years after surgery. Therefore, the overall study duration is estimated to be 36 months.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
A. Shoe modification B. Nonsteroidal anti-inflammatory drugs C. Physical Therapy with/without modalities
Exclusion criteria
Placement of bioinductive implant over repair of insertional Achilles tendinopathy
Time frame: 3, 12, and 24 months
Measurement of new tissue thickness in millimeters will be made from sagittal magnetic resonance imaging (MRI) at the level of the bone anchor. These measurements were made distal to the attachment of the Achilles tendon, which do not include the thickness of the repaired tendon; therefore, these thicknesses represent the thickness of the newly induced tissue only.
Time frame: 3, 12, and 24 months
Combined measurement of tendon and new tissue thickness in millimeters will be made from sagittal magnetic resonance imaging (MRI) at the insertion (approximately 5-10mm proximal to the bone anchor).
Time frame: following surgery to end of treatment at 24 months
Tear rate in the deep portion of the repair at the calcaneus following Achilles surgery will be assessed at each follow-up visit using magnetic resonance imaging (MRI).
Time frame: Intraoperatively, up to 9 minutes
Time in minutes from introduction of the bioinductive implant into the surgical field to completion of the last staple
Time frame: Intraoperatively, up to 9 minutes
The number of participants where the device was successfully delivered and affixed to target tendon location (i.e., study device was successfully implanted).
Time frame: 1 week following surgery to 12 months
Cumulative number of days spent in a controlled ankle motion walking boot (CAM boot).
Time frame: 4 weeks following surgery to end of treatment at 24 months
Rehabilitation measured by the cumulative number of completed rehabilitation or physical therapy (PT) visits to treat index Achilles.
Time frame: following surgery to end of treatment at 24 months
Recovery will be measured by days to return to normal daily activity (i.e. full, unrestricted activity).
Time frame: 12 months
Participant Satisfaction will determined based on the response to the statement "I am satisfied with the results of my surgery." The response will be assessed with a 5-point Likert scale, which has 1 - very dissatisfied, 2 - dissatisfied, 3 - neither satisfied nor dissatisfied, 4 - satisfied, 5 - very satisfied
Smith & Nephew, Inc.
Industry
Evaluation of the Rotation Medical Bioinductive Implant for Insertional Achilles Tendinopathy
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03287596
Arthritis, Bone Diseases
Bordeaux, France
View Trial DetailsNCT07261449
Muscular Diseases, Musculoskeletal Diseases
Salamanca, Spain
View Trial DetailsNCT05569174
Muscular Diseases, Musculoskeletal Diseases
Karlsruhe, Baden-Wurttemberg, Germany
View Trial DetailsNCT04753853
Muscular Diseases, Musculoskeletal Diseases
Bologna, Italy
View Trial Details